Triple
T19036302
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | David Baulcombe |
E465882
|
entity |
| Predicate | fieldOfWork |
P3
|
FINISHED |
| Object | RNA silencing |
—
|
NE NERFINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: RNA silencing | Statement: [David Baulcombe, fieldOfWork, RNA silencing]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: RNA silencing Context triple: [David Baulcombe, fieldOfWork, RNA silencing]
-
A.
RNA interference pathway
chosen
The RNA interference pathway is a cellular mechanism in which small RNA molecules guide the sequence-specific silencing of target genes, typically by promoting the degradation or translational repression of complementary messenger RNAs.
-
B.
CRISPR-Cas systems
CRISPR-Cas systems are adaptive immune mechanisms found in bacteria and archaea that have been repurposed as powerful, programmable tools for genome editing and gene regulation.
-
C.
RNA
RNA (Ribonucleic Acid) is a vital biological macromolecule that plays key roles in coding, decoding, regulation, and expression of genes in all living organisms.
-
D.
RNA therapeutics
RNA therapeutics are medical treatments that use RNA molecules to modulate gene expression or protein production for preventing, treating, or curing disease.
-
E.
CRISPR-Cas9 gene-editing technology
CRISPR-Cas9 gene-editing technology is a revolutionary molecular tool that allows scientists to precisely modify DNA within living organisms, transforming research, medicine, and biotechnology.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d8dd0359648190bc2a9202c5cf29d2 |
completed | April 10, 2026, 11:20 a.m. |
| NER | Named-entity recognition | batch_69e5d7438f748190912c28912e6b97a6 |
completed | April 20, 2026, 7:35 a.m. |
Created at: April 10, 2026, 12:02 p.m.